Similar articles

• Effect of selective monoamine oxidase inhibitors on rat brain mitochondrial monoamine oxidase during hyperbaric oxygenation.

  Goroshinskaya IA, Bronovizkaya ZG, Gorkin VZ. Goroshinskaya IA, et al. Commun Psychopharmacol. 1977;1(1):39-47. Commun Psychopharmacol. 1977. PMID: 606471 No abstract available.
• Modification of brain mitochondrial monoamine oxidase activities by hydroxyethylhydrazide of cyanoacetic acid and some other monoamine oxidase inhibitors.

  Baumanis EA, Kalnina IE, Moskvitina TA, Gorkin VZ. Baumanis EA, et al. Biochem Pharmacol. 1977 Jun 1;26(11):1059-63. doi: 10.1016/0006-2952(77)90244-1. Biochem Pharmacol. 1977. PMID: 18152 No abstract available.
• [Effect of various antidepressive agents on brain monoamine oxidase activity].

  Gankina EM, Moskvitina TA, Gorkin VZ, Val'dman AV. Gankina EM, et al. Biull Eksp Biol Med. 1982 Nov;94(11):29-31. Biull Eksp Biol Med. 1982. PMID: 7150732 Russian.
• [Recent advances in multiple forms, type A and type B, of mitochondrial monoamine oxidase (author's transl)].

  Kinemuchi H, Kamijo K. Kinemuchi H, et al. Tanpakushitsu Kakusan Koso. 1980 Dec;25(13):1069-86. Tanpakushitsu Kakusan Koso. 1980. PMID: 7025101 Review. Japanese. No abstract available.
• The use of selective monoamine oxidase inhibitor drugs to modify amine metabolism in brain.

  Neff NH, Yang HY, Fuentes JA. Neff NH, et al. Adv Biochem Psychopharmacol. 1974;12(0):49-57. Adv Biochem Psychopharmacol. 1974. PMID: 4609330 Review. No abstract available.